Case number 2018-1522
Hospira Inc. v. Amneal Pharmaceuticals LLC > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | HOSPIRA INC. v. AMNEAL PHARMACEUTICALS LLC [RULE 36 JUDGMENT] [nonprecedential] (0) |
| Apr 2, 2019 | 59 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [597083] [PBC] [Entered: 04/02/2019 09:56 AM] (1) |
| Mar 26, 2019 | 58 | ORDER filed denying [56] petition for panel rehearing filed by Amneal Pharmaceuticals LLC; denying [56] petition for en banc rehearing filed by Amneal Pharmaceuticals LLC. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [595556] [PBC] [Entered: 03/26/2019 02:25 PM] (2) |
| Feb 22, 2019 | 57 | 18 paper copies of the petition for panel rehearing [56], petition for en banc rehearing [56] received from Appellant Amneal Pharmaceuticals LLC. [588166] [JAB] [Entered: 02/22/2019 05:39 PM] (0) |
| Feb 21, 2019 | 56 | Petition for panel rehearing, for en banc rehearing filed by Appellant Amneal Pharmaceuticals LLC. Service: 02/21/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 02/25/2019 [587715] [18-1522] [Steven Maddox] [Entered: 02/21/2019 03:19 PM] (27) |
| Jan 22, 2019 | 55 | JUDGMENT filed. AFFIRMED. Issued pursuant to Federal Circuit Rule 36. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [579538] [PBC] [Entered: 01/22/2019 09:20 AM] (2) |
| Jan 10, 2019 | 54 | Submitted after ORAL ARGUMENT by Steven Arthur Maddox for Amneal Pharmaceuticals LLC and Bradford Peter Lyerla for Hospira Inc. Panel: Judge: Newman , Judge: O'Malley , Judge: Chen. [577265] [JAB] [Entered: 01/10/2019 11:17 AM] (0) |
| Dec 26, 2018 | 53 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellant Amneal Pharmaceuticals LLC. Service: 12/22/2018 by email. [574337] [18-1522] [Steven Maddox] [Entered: 12/22/2018 08:12 AM] (2) |
| Dec 21, 2018 | 52 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellee Hospira Inc.. Service: 12/21/2018 by email. [574100] [18-1522] [Bradford Lyerla] [Entered: 12/21/2018 01:31 PM] (57) |
| Dec 11, 2018 | 51 | Response to notice of oral argument from the Appellant Amneal Pharmaceuticals LLC. [571039] [18-1522] [Steven Maddox] [Entered: 12/11/2018 05:15 PM] (3) |
| Dec 6, 2018 | 50 | Response to notice of oral argument from the Appellee Hospira Inc.. [569875] [18-1522] [Bradford Lyerla] [Entered: 12/06/2018 11:39 AM] (3) |
| Nov 19, 2018 | 49 | NOTICE OF ORAL ARGUMENT. Panel: 1901K. Case scheduled Jan 10, 2019 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, NW Washington, DC 20439), Courtroom 402. Response to Notice of Oral Argument due: 12/17/2018. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. [566380] [JAB] [Entered: 11/19/2018 03:20 PM] (2) |
| Aug 17, 2018 | 48 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re:party letter Docket No. [47], ERROR: Document was submitted using the incorrect event. CORRECTION: Please ensure that future argument scheduling conflict notices are filed using the "Notice Regarding Conflicts with Argument Dates" event, rather than "Letter or Notice from Party". [543603] [JAB] [Entered: 08/17/2018 09:06 AM] (0) |
| Aug 16, 2018 | 47 | Notice from Appellee Hospira Inc. Notice Regarding Conflicts with Argument Dates. Service: 08/16/2018 by email. [543434] [18-1522] [Bradford Lyerla] [Entered: 08/16/2018 02:02 PM] (2) |
| Aug 15, 2018 | 46 | Notice from Appellant Amneal Pharmaceuticals LLC regarding conflicts with oral argument (none). Service: 08/15/2018 by email. [543028] [18-1522] [Steven Maddox] [Entered: 08/15/2018 12:05 PM] (1) |
| Aug 13, 2018 | 45 | 6 paper copies of the Joint Appendix Brief in 2 Volumes [43] received from Appellant Amneal Pharmaceuticals LLC. [542619]--[Edited 08/14/2018 by JCP to add volumes] [CJF] [Entered: 08/14/2018 09:29 AM] (0) |
| Aug 10, 2018 | 44 | Pursuant to Practice Note 34, counsel should advise the clerk of court of scheduling conflicts for the next three court weeks [OCT, NOV, DEC], or thereafter. When filing the notice of conflicts, counsel should docket the Notice Regarding Conflicts with Argument Dates event, which is found in the Calendar event category. The notice of conflict with oral argument is due on or before 08/17/2018. [542117] [MJL] [Entered: 08/10/2018 02:11 PM] (0) |
| Jul 31, 2018 | 43 | APPENDIX FILED for Amneal Pharmaceuticals LLC [40]. Number of Pages: 476. Service: 07/31/2018 by email. The paper copies of the appendix should be received by the court on or before 08/17/2018. [542111] [MJL] [Entered: 08/10/2018 02:05 PM] (476) |
| Jul 31, 2018 | 42 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Amneal Pharmaceuticals LLC. Service: 07/31/2018 by email. [539899] [18-1522] [Steven Maddox] [Entered: 07/31/2018 06:56 PM] (3) |
| Jul 31, 2018 | 41 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Hospira Inc.. Service: 07/31/2018 by email. [539890] [18-1522] [Bradford Lyerla] [Entered: 07/31/2018 06:02 PM] (3) |
| Jul 31, 2018 | 40 | TENDERED from Appellant Amneal Pharmaceuticals LLC and Appellee Hospira Inc.. Title: JOINT APPENDIX. Service: 07/31/2018 by email. [539888] [18-1522] [Steven Maddox] [Entered: 07/31/2018 05:38 PM] (476) |
| Jul 31, 2018 | 39 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Amneal Pharmaceuticals LLC and Appellee Hospira Inc.. Service: 07/31/2018 by email. [539746] [18-1522] [Steven Maddox] [Entered: 07/31/2018 01:37 PM] (3) |
| Jul 27, 2018 | 38 | 6 paper copies of the Reply Brief [35] received from Appellant Amneal Pharmaceuticals LLC. [539001] [CJF] [Entered: 07/27/2018 11:08 AM] (0) |
| Jul 25, 2018 | 37 | Amended Certificate of Interest for the Appellant Amneal Pharmaceuticals LLC. Service: 07/25/2018 by email. [538466] [18-1522] [Steven Maddox] [Entered: 07/25/2018 10:45 AM] (2) |
| Jul 25, 2018 | 36 | REMINDER: All counsel of record are reminded of their responsibility per FCR 47.3(c)(1) and 47.4(c) to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. The court notes that the COI attached to appellant's reply brief [35] includes information that is different from the information on the amended COI [28]. Appellant must promptly file a copy of the most up-to-date COI as a separate docket entry. [538366] [MJL] [Entered: 07/25/2018 08:55 AM] (0) |
| Jul 24, 2018 | 35 | REPLY BRIEF FILED for Appellant Amneal Pharmaceuticals LLC [34]. Number of Pages: 29. Service: 07/24/2018 by email. The paper copies of the brief should be received by the court on or before 08/01/2018. Appendix is due 07/31/2018. [538363] [MJL] [Entered: 07/25/2018 08:51 AM] (38) |
| Jul 24, 2018 | 34 | TENDERED from Appellant Amneal Pharmaceuticals LLC. Title: REPLY BRIEF. Service: 07/24/2018 by email. [538229] [18-1522] [Steven Maddox] [Entered: 07/24/2018 03:24 PM] (38) |
| Jun 26, 2018 | 33 | 6 paper copies of the Opening Response Brief [31] received from Appellee Hospira Inc.. [531974] [CJF] [Entered: 06/26/2018 12:43 PM] (0) |
| Jun 25, 2018 | 30 | ORDER granting motions [530424-2] and [29]. Appeal 18-1668 is dismissed. The revised official caption for 18-1522 is reflected in the order. Amneal's reply brief is due 07/24/2018. A copy of this order shall be transmitted to the merits panel. ISSUED AS A MANDATE (as to 18-1668 only). Service as of this date by the Clerk of Court. [531650] [18-1522, 18-1668] [MJL] [Entered: 06/25/2018 12:01 PM] (3) |
| Jun 25, 2018 | 32 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: ERROR: Appellant's motion [29] did not include a certificate of compliance. CORRECTION: Pursuant to FRAP 32(g)(1), motions must contain a certificate of compliance with the word count. Please ensure future motions include the certificate of compliance. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [531715] [MJL] [Entered: 06/25/2018 02:11 PM] (0) |
| Jun 21, 2018 | 29 | MOTION of Appellant Amneal Pharmaceuticals LLC to extend the time to 07/24/2018 to file the Reply Brief. [Consent: unopposed]. Service: 06/21/2018 by email. [531340] [18-1522] [Steven Maddox] [Entered: 06/21/2018 06:06 PM] (10) |
| Jun 21, 2018 | 28 | Amended Certificate of Interest for the Appellant Amneal Pharmaceuticals LLC. Service: 06/21/2018 by email. [531338] [18-1522] [Steven Maddox] [Entered: 06/21/2018 06:03 PM] (3) |
| Jun 18, 2018 | 31 | BRIEF FILED for Appellee Hospira Inc. [27]. Number of Pages: 56. Service: 06/18/2018 by email. The paper copies of the brief should be received by the court on or before 07/02/2018. [531655] [MJL] [Entered: 06/25/2018 12:10 PM] (66) |
| Jun 18, 2018 | 27 | TENDERED from Cross-Appellant Hospira Inc.. Title: RESPONSE BRIEF. Service: 06/18/2018 by email. [530425] [18-1522] [Bradford Lyerla] [Entered: 06/18/2018 10:50 PM] (66) |
| Apr 16, 2018 | 26 | ORDER filed. The motion [25] is denied. No further extensions will be granted. Service: 04/16/2018 by clerk. [513573] [LMS] [Entered: 04/16/2018 11:16 AM] (2) |
| Apr 12, 2018 | 25 | MOTION of Appellant Amneal Pharmaceuticals LLC to reconsider clerk order [23], [24]. Response/Opposition is due 04/23/2018 [Consent: opposed]. Service: 04/12/2018 by email. [512890] [18-1522]--[Edited 04/16/2018 by MJL to correct docket text]. [Steven Maddox] [Entered: 04/12/2018 01:58 PM] (13) |
| Apr 12, 2018 | 24 | CORRECTED ORDER: correcting clerk order [23]; reason: to correct consent status. Service as of this date by the Clerk of Court. [512851] [CAB] [Entered: 04/12/2018 12:38 PM] (2) |
| Apr 12, 2018 | 23 | ORDER granting motion to extend time to file brief [22] filed by Cross-Appellant Hospira Inc. Brief due 06/18/2018. Service as of this date by the Clerk of Court. [512835] [CFT] [Entered: 04/12/2018 11:36 AM] (0) |
| Apr 11, 2018 | 22 | MOTION of Cross-Appellant Hospira Inc. to extend the time to 06/18/2018 to file the Principal and Response Brief.. Any response is due within 10 days of service. [Consent: opposed]. Service: 04/11/2018 by email. [512674] [18-1522] [Bradford Lyerla] [Entered: 04/11/2018 07:18 PM] (10) |
| Apr 4, 2018 | 20 | Entry of appearance for Adam G. Unikowsky as of counsel for Cross-Appellant Hospira Inc.. Service: 04/04/2018 by email. [510502] [18-1522] [Adam Unikowsky] [Entered: 04/04/2018 10:37 AM] (2) |
| Apr 3, 2018 | 21 | 6 paper copies of the Corrected Opening Brief [19] received from Appellant Amneal Pharmaceuticals LLC. [510943] [SJL] [Entered: 04/05/2018 02:20 PM] (0) |
| Mar 28, 2018 | 19 | CORRECTED BRIEF FILED for Appellant Amneal Pharmaceuticals LLC [18]. Number of Pages: 63. Service: 03/28/2018 by email. The paper copies of the brief should be received by the court on or before 04/06/2018. [509620] [JB] [Entered: 03/30/2018 02:59 PM] (191) |
| Mar 28, 2018 | 18 | TENDERED from Appellant Amneal Pharmaceuticals LLC. Title: CORRECTED OPENING BRIEF. Service: 03/28/2018 by email. [508731] [18-1522] [Steven Maddox] [Entered: 03/28/2018 02:41 PM] (191) |
| Mar 28, 2018 | 17 | NOTICE OF REJECTION: The Opening Brief of Defendant-Appellant Amneal Pharmaceuticals LLC [16] is not in compliance with the rules of this court and is therefore rejected for filing. Corrected brief due 04/11/2018. Cross-Appellant Hospira Inc.'s brief is due 05/02/2018. Service as of this date by the Clerk of Court. [508602] [MJL] [Entered: 03/28/2018 11:24 AM] (2) |
| Mar 23, 2018 | 16 | TENDERED from Appellant Amneal Pharmaceuticals LLC. Title: OPENING BRIEF. Service: 03/23/2018 by email. [507614] [18-1522]. This brief has been rejected. See Doc. No. [17]. [Steven Maddox] [Entered: 03/23/2018 03:21 PM] (0) |
| Mar 12, 2018 | 15 | Official caption revised to reflect cross-appeal. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [504199] [MJL] [Entered: 03/12/2018 01:54 PM] (0) |
| Mar 12, 2018 | 14 | Note to file: The following cases are consolidated: 18-1522 (Lead) with 18-1668 (Cross-Appeal). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [504198] [18-1522, 18-1668] [MJL] [Entered: 03/12/2018 01:53 PM] (0) |
| Feb 20, 2018 | 13 | Docketing Statement for the Appellee Hospira Inc.. Service: 02/20/2018 by email. [499357] [Bradford Lyerla] [Entered: 02/20/2018 01:45 PM] (3) |
| Feb 20, 2018 | 12 | Certificate of Interest for the Appellee Hospira Inc.. Service: 02/20/2018 by email. [499353] [Bradford Lyerla] [Entered: 02/20/2018 01:42 PM] (3) |
| Feb 20, 2018 | 11 | Entry of appearance for Sara Tonnies Horton as of counsel for Appellee Hospira Inc.. Service: 02/20/2018 by email. [499350] [Sara Horton] [Entered: 02/20/2018 01:37 PM] (2) |
| Feb 20, 2018 | 10 | Entry of appearance for Ren-How H. Harn as of counsel for Appellee Hospira Inc.. Service: 02/20/2018 by email. [499345] [Ren-How Harn] [Entered: 02/20/2018 01:33 PM] (2) |
| Feb 20, 2018 | 9 | Entry of appearance for Yusuf Esat as of counsel for Appellee Hospira Inc.. Service: 02/20/2018 by email. [499341] [Yusuf Esat] [Entered: 02/20/2018 01:30 PM] (2) |
| Feb 20, 2018 | 8 | Entry of appearance for Bradford P. Lyerla as principal counsel for Appellee Hospira Inc.. Service: 02/20/2018 by email. [499339] [Bradford Lyerla] [Entered: 02/20/2018 01:24 PM] (2) |
| Feb 15, 2018 | 7 | Docketing Statement for the Appellant Amneal Pharmaceuticals LLC. Service: 02/15/2018 by email. [498096] [Steven Maddox] [Entered: 02/15/2018 02:02 PM] (6) |
| Feb 15, 2018 | 6 | Certificate of Interest for the Appellant Amneal Pharmaceuticals LLC. Service: 02/15/2018 by email. [498093] [Steven Maddox] [Entered: 02/15/2018 02:01 PM] (3) |
| Feb 15, 2018 | 5 | Entry of appearance for Kaveh Saba as of counsel for Appellant Amneal Pharmaceuticals LLC. Service: 02/15/2018 by email. [498091] [Steven Maddox] [Entered: 02/15/2018 02:00 PM] (2) |
| Feb 15, 2018 | 4 | Entry of appearance for Matthew C. Ruedy as of counsel for Appellant Amneal Pharmaceuticals LLC. Service: 02/15/2018 by email. [498090] [Steven Maddox] [Entered: 02/15/2018 01:59 PM] (2) |
| Feb 15, 2018 | 3 | Entry of appearance for Jeremy J. Edwards as of counsel for Appellant Amneal Pharmaceuticals LLC. Service: 02/15/2018 by email. [498087] [Steven Maddox] [Entered: 02/15/2018 01:58 PM] (2) |
| Feb 15, 2018 | 2 | Entry of appearance for Steven A. Maddox as principal counsel for Appellant Amneal Pharmaceuticals LLC. Service: 02/15/2018 by email. [498085] [Steven Maddox] [Entered: 02/15/2018 01:55 PM] (2) |
| Feb 6, 2018 | 1 | Appeal docketed. Received: 02/06/2018. [495680]Entry of Appearance due 02/20/2018. Certificate of Interest due 02/20/2018. Docketing Statement due 02/20/2018. Appellant's brief due 04/09/2018. [MJL] [Entered: 02/06/2018 04:09 PM] (74) |
